A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfadoxine
Dexetimide
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
Sulfadoxine
Aclidinium
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
Sulfadoxine
Dimetindene
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
Sulfadoxine
Hexocyclium
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
Sulfadoxine
Pizotifen
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.
Sulfadoxine
Mepenzolate
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
Sulfadoxine
Isopropamide
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
Sulfadoxine
Solifenacin
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Sulfadoxine
Lumacaftor
The serum concentration of Pomalidomide can be decreased when it is combined with Lumacaftor.
Sulfadoxine
Alaproclate
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Alaproclate.
Sulfadoxine
Ritanserin
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ritanserin.
Sulfadoxine
Levomilnacipran
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Levomilnacipran.
Sulfadoxine
Cyproterone acetate
The metabolism of Pomalidomide can be increased when combined with Cyproterone acetate.
Sulfadoxine
Incadronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Pomalidomide is combined with Incadronic acid.
Sulfadoxine
Tofacitinib
Pomalidomide may increase the immunosuppressive activities of Tofacitinib.
Sulfadoxine
Metamizole
The risk or severity of myelosuppression can be increased when Metamizole is combined with Pomalidomide.
Sulfadoxine
Metreleptin
The metabolism of Pomalidomide can be increased when combined with Metreleptin.
Sulfadoxine
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.
Sulfadoxine
Suvorexant
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Sulfadoxine
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3